MS
Price
$165.67Alerts
Change
-$9.31 (-5.32%)
Updated
Nov 20 closing price
Capitalization
284.96B
53 days until earnings call
Intraday BUY SELL Signals
NMR
Price
$8.51Alerts
Change
-$0.53 (-5.86%)
Updated
Nov 20 closing price
Capitalization
27.53B
73 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

MS vs NMR

MS vs NMR Comparison Chart in %
View a ticker or compare two or three
VS
MS vs. NMR commentary
Nov 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MS is a Hold and NMR is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for MS with price predictions
Nov 20, 2026

MS sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for MS moved below the 200-day moving average on November 12, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MS as a result. In 41 of 72 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 57%.

The Moving Average Convergence Divergence Histogram (MACD) for MS turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 24 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 55%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for MS's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +1.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where MS advanced for three days, in 230 of 349 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

MS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 167 of 304 cases where MS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 5 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 29 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating steady price growth. MS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 62 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.674) is normal, around the industry mean (3.143). P/E Ratio (14.515) is within average values for comparable stocks, (6.733). Projected Growth (PEG Ratio) (1.702) is also within normal values, averaging (0.809). Dividend Yield (0.025) settles around the average of (8.975) among similar stocks. P/S Ratio (4.380) is also within normal values, averaging (17.075).

A.I.Advisor
a Summary for NMR with price predictions
Nov 20, 2026

NMR's Indicator enters downward trend

The Aroon Indicator for NMR entered a downward trend on November 03, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 138 similar instances where the Aroon Indicator formed such a pattern. In 89 of the 138 cases the stock moved lower. This puts the odds of a downward move at 64%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NMR as a result. In 43 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 53%.

The Moving Average Convergence Divergence Histogram (MACD) for NMR turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 27 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 56%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NMR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for NMR's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a +3.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where NMR advanced for three days, in 206 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

NMR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 1 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. NMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.007) is normal, around the industry mean (3.143). P/E Ratio (0.068) is within average values for comparable stocks, (6.733). Projected Growth (PEG Ratio) (0.815) is also within normal values, averaging (0.809). Dividend Yield (0.041) settles around the average of (8.975) among similar stocks. P/S Ratio (2.472) is also within normal values, averaging (17.075).

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

FUNDAMENTALS RATINGS
MS vs NMR: Fundamental Ratings
MS
NMR
OUTLOOK RATING
1..100
1357
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
2922
SMR RATING
1..100
51
PRICE GROWTH RATING
1..100
6155
P/E GROWTH RATING
1..100
6297
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NMR's Valuation (78) in the Investment Banks Or Brokers industry is in the same range as MS (92). This means that NMR’s stock grew similarly to MS’s over the last 12 months.

NMR's Profit vs Risk Rating (22) in the Investment Banks Or Brokers industry is in the same range as MS (29). This means that NMR’s stock grew similarly to MS’s over the last 12 months.

NMR's SMR Rating (1) in the Investment Banks Or Brokers industry is in the same range as MS (5). This means that NMR’s stock grew similarly to MS’s over the last 12 months.

NMR's Price Growth Rating (55) in the Investment Banks Or Brokers industry is in the same range as MS (61). This means that NMR’s stock grew similarly to MS’s over the last 12 months.

MS's P/E Growth Rating (62) in the Investment Banks Or Brokers industry is somewhat better than the same rating for NMR (97). This means that MS’s stock grew somewhat faster than NMR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MSNMR
RSI
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
65%
Momentum
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 3 days ago
53%
MACD
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 3 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
58%
Bearish Trend 3 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
58%
Bearish Trend 3 days ago
56%
Advances
ODDS (%)
Bullish Trend 12 days ago
66%
Bullish Trend 25 days ago
68%
Declines
ODDS (%)
Bearish Trend 3 days ago
61%
Bearish Trend 3 days ago
54%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
64%
Aroon
ODDS (%)
Bullish Trend 3 days ago
55%
Bearish Trend 3 days ago
64%
COMPARISON
Comparison
Nov 22, 2026
Stock price -- (MS: $165.67 vs. NMR: $8.51)
Brand notoriety: MS: Notable vs. NMR: Not notable
Both companies represent the Investment Banks/Brokers industry
Current volume relative to the 65-day Moving Average: MS: 169% vs. NMR: 201%
Market capitalization -- MS: $284.96B vs. NMR: $27.53B
MS [@Investment Banks/Brokers] is valued at $284.96B. NMR’s [@Investment Banks/Brokers] market capitalization is $27.53B. The market cap for tickers in the [@Investment Banks/Brokers] industry ranges from $590 to $284.96B. The average market capitalization across the [@Investment Banks/Brokers] industry is $11.61B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MS’s FA Score shows that 2 FA rating(s) are green while NMR’s FA Score has 2 green FA rating(s).

  • MS’s FA Score: 2 green, 3 red.
  • NMR’s FA Score: 2 green, 3 red.
According to our system of comparison, MS is a better buy in the long-term than NMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MS’s TA Score shows that 5 TA indicator(s) are bullish while NMR’s TA Score has 4 bullish TA indicator(s).

  • MS’s TA Score: 5 bullish, 4 bearish.
  • NMR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, MS is a better buy in the short-term than NMR.

Price Growth

MS (@Investment Banks/Brokers) experienced а -13.10% price change this week, while NMR (@Investment Banks/Brokers) price change was -12.27% for the same time period.

The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -13.59%. For the same industry, the average monthly price growth was -25.99%, and the average quarterly price growth was -34.02%.

Reported Earning Dates

MS is expected to report earnings on Jan 14, 2027.

NMR is expected to report earnings on Feb 03, 2027.

Industries' Descriptions

@Investment Banks/Brokers (-13.59% weekly)

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

View a ticker or compare two or three
Interact to see
Advertisement

NMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NMR has been loosely correlated with MS. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if NMR jumps, then MS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NMR
1D Price
Change %
NMR100%
-5.86%
MS - NMR
55%
Loosely correlated
-5.32%
GS - NMR
54%
Loosely correlated
-6.71%
MCO - NMR
49%
Loosely correlated
-0.85%
LAZ - NMR
49%
Loosely correlated
-5.32%
RJF - NMR
49%
Loosely correlated
-1.93%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EFSC58.13-0.88
-1.49%
Enterprise Financial Services Corp
HALO91.35-1.69
-1.82%
Halozyme Therapeutics
YB10.61-0.43
-3.89%
Yuanbao Inc
OKYO1.10-0.06
-5.17%
OKYO Pharma Limited
ISPC0.46-0.07
-13.58%
iSpecimen Inc.